Tinnitus News

Between November 2019 and November 2022, the University of Michigan and Apple Inc. collaborated by surveying over 160,000 iPhone users in order to gain insights into contemporary tinnitus prevalence rates and symptom characteristics. Participants answered survey questions and completed app-based assessments to characterize their experience of tinnitus. This research aims to improve the understanding of […]

In this review of contemporary tinnitus research, the prominent academic, Will Sedley, summarises the recent advancements in the aetiological modelling of subject tinnitus and describes novel therapeutic approaches that may serve to reduce the severity of patient symptoms. The innovative Lenire® system is referenced within the article as a novel approach for the treatment of bothersome subjective tinnitus. […]

The Tinnitus Clinic Ltd. is the major provider of the innovative Lenire tinnitus therapy system within the UK. Lenire, the first and only CE and FDA approved tinnitus treatment device utilising bimodal (tactile and sound stimulation) and has been featured in the latest Textbook of Tinnitus:https://link.springer.com/book/10.1007/978-3-031-35647-6 You can read about Lenire’s “remarkable” clinical trial results […]

The acclaimed hearing aid manufacturer Starkey Hearing Technologies has just launched their newest instrument platform Gensis AI in the UK. The Genesis AI features an advanced processor, a long-lasting rechargeable battery (51 hours from a single charge) along with an award-winning ergonomic shell design for improved wearing comfort. Genesis AI’s all-new Starkey Neuro Processor is […]

The renowned hearing aid manufacturer Widex is in the process of commercialising a new type of hearing aid system that is specifically designed to help patients with tinnitus and milder hearing losses. Patients with mild hearing loss whose main complaint is tinnitus may benefit from amplification, in order to reduce their tinnitus perception, but often […]

We are delighted to report that Neuromod Devices Ltd. has been granted approval by the Food and Drugs Administration (FDA) to supply the Lenire tinnitus therapy system to patients in the U.S. This is the first time that a bimodal neuromodulation system has ever been grated FDA approval for the treatment of subjective tinnitus and […]

Earlier this week a new study investigating the impact of long COVID was published by University College Cork (UCC)1. This study involved 988 participants with 90% of participants reporting that they still have not returned to their pre COVID level of health and that their current symptoms were not present prior to contracting the virus. […]

In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine’s side effects has become an important global health concern. In the present study, researchers determined the proportion of patients who […]

The results of the second randomised controlled trial (RCT) examining the efficacy of the Lenire tinnitus therapy system have now been published in the respected journal "Nature - Scientific Reports".

New AI-enabled hearing aids from Starkey can help isolate sounds that a user would prefer to hear from complex background noise.

A new “real-word”, 20 patient study (Buechner et al 2022) investigating the effectiveness of Lenire in alleviating tinnitus symptoms has been shown that over a 6-12 week treatment period, 86.2% of participants reported a clinically significant improvement in their tinnitus Nb id rather say 8 out of 10 than 86.2%.

Biotech company Frequency Therapeutics is seeking to reverse hearing loss with a new form of regenerative therapy.